Omeros Savors Sweet Success In Phase III Ophthalmology Trial
By Catherine Shaffer
Wednesday, March 14, 2012
A Phase III trial of a product in development to prevent complications during delicate intraocular lens replacement surgery met its primary and secondary endpoints, Omeros Corp. reported Tuesday.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.